Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie’s Disease

Volume: 195, Issue: 4, Pages: 1051 - 1056
Published: Apr 1, 2016
Abstract
Purpose: Collagenase clostridium histolyticum is approved for the treatment of Peyronie’s disease. To date, no post-release study to our knowledge has evaluated patient perceived outcomes and satisfaction. Therefore, we evaluated patient perceived experience with collagenase clostridium histolyticum injection for Peyronie’s disease in a clinical practice.Materials and Methods: From March 2014 to July 2015, 69 patients underwent 1 to 4 series of...
Paper Details
Title
Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie’s Disease
Published Date
Apr 1, 2016
Volume
195
Issue
4
Pages
1051 - 1056
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.